Who Paid My Doc
Alejandro Berenstein
Neurological Surgery New York, NY Medical Doctor
NPI 1790766848 CMS profile 171657
1450 Madison Avenue #1136, New York, NY 10029
General payments
$1,104,801
Research payments
$45,285
Ownership & investment interest
$1,016,570
Through program year 2025, Alejandro Berenstein of New York, NY is reported in the CMS Open Payments database as having received $1,104,801 across 93 general payments and $45,285 in research payments paid to them. They also declared ownership or investment interests valued at $1,016,570 across 10 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 98th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
17 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $174,798 | 10 | |
| 2025 | Research | $14,196 | 1 | |
| 2024 | General | $156,010 | 7 | |
| 2023 | General | $151,503 | 20 | |
| 2022 | General | $143,462 | 8 | |
| 2022 | Research | $390 | 1 | |
| 2021 | General | $205,564 | 14 | |
| 2020 | General | $132,066 | 8 | |
| 2019 | General | $141,397 | 26 | |
| 2019 | Research | $30,700 | 5 | |
| 2025 | Ownership | $205,475 | 2 | |
| 2024 | Ownership | $190,937 | 2 | |
| 2023 | Ownership | $138,566 | 1 | |
| 2022 | Ownership | $165,263 | 1 | |
| 2021 | Ownership | $213,358 | 1 | |
| 2020 | Ownership | $51,698 | 1 | |
| 2019 | Ownership | $51,274 | 2 |
Beside peers
- Alejandro Berenstein
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to Alejandro Berenstein were reported at $174,798. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | Alejandro Berenstein | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $141,397 | $582 | $138–$3,006 | $163 |
| 2020 | $132,066 | $294 | $76–$2,174 | $114 |
| 2021 | $205,564 | $387 | $105–$2,432 | $132 |
| 2022 | $143,462 | $542 | $139–$2,989 | $149 |
| 2023 | $151,503 | $534 | $145–$2,697 | $160 |
| 2024 | $156,010 | $574 | $155–$3,046 | $164 |
| 2025 | $174,798 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
100 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in New York
Ryan Denhaese
Neurological Surgery · Williamsville, NY
J Mocco
Neurological Surgery · New York, NY
Adnan Siddiqui
Neurological Surgery · Williamsville, NY
Leo Hopkins
Neurological Surgery · Buffalo, NY
Aziz Basem Qandah
Neurological Surgery · New Hartford, NY
Darryl Lau
Neurological Surgery · New York, NY
Related records
Neurological Surgery in New York
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.